Senior insider sale
Chief Financial Officer at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$339.7K
1.80K shares
What this filing means
ESPINOZA OCTAVIO plans to sell 1.80K shares of LIGAND PHARMACEUTICALS INC valued at approximately $339.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001950047-25-010259
Officer· Chief Financial Officer
Since Mar 2026
1.80K
Shares to sell
$339.7K
Approx. market value
1.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
12/5/2025
1.80KTotal acquired1.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/5/2025 | Restricted Stock Not Applicable | 1.80K | — |
| Total | 1.80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.80K
Market value
$339.7K
12/12/2025
Total
Units
1.80K
Value
$339.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 1.80K | $339.7K | NASDAQ | Planned |
| Total | 1.80K | $339.7K | ||